Virginia Metrangolo
iMED publications
1 - 1 out of 1Page size: 10
- 2021
- Published
The Urokinase Receptor (uPAR) as a “Trojan Horse” in Targeted Cancer Therapy: Challenges and Opportunities
Metrangolo, Virginia, Ploug, Michael & Engelholm, Lars Henning, 2021, In: Cancers. 13, 21, 45 p., 5376.Research output: Contribution to journal › Review › Research › peer-review
ID: 217189136
Most downloads
-
12
downloads
The Urokinase Receptor (uPAR) as a “Trojan Horse” in Targeted Cancer Therapy: Challenges and Opportunities
Research output: Contribution to journal › Review › Research › peer-review
Published